Overall, this study showed significant dysregulation of SPMs and an attempt at inflammation resolution to compensate for the pro-inflammatory environment by increasing SPM receptors, an SPM biosynthetic enzyme (15-LOX2) and PPARγ in the AD brain. This evidence concerns the gene ALOX15B and Alzheimer disease.